stocktools
Offerings // CNS Pharmaceuticals, Inc.

CNSP offering history

Every offering-related filing in CNS Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 390 filings back to Mar 13, 2018.

Last executed offering
May 4, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
May 19, 2026
S-3 — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
May 26, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 26, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 19, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 4, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 19, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 14, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
May 13, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 12, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Apr 14, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Mar 20, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 24, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 2, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 31, 2024RW →WITHDRAWNRegistration withdrawn
Jul 30, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 30, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 26, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 19, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 12, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jul 5, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 3, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 27, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 26, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 17, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 14, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 10, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
May 17, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 9, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jan 31, 2024424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jan 29, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 22, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jan 10, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Dec 8, 2023S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Nov 30, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 30, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 20, 2023S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Oct 17, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 5, 2022424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Nov 30, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 28, 2022S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Nov 15, 2022S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
CNSP offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full CNSP workspace →
CNSP offering FAQ

When did CNSP last execute an offering?

Per SEC filings, CNS Pharmaceuticals, Inc.'s most recent priced offering document is a 8-K filed 2026-05-04. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did CNSP last announce or register an offering?

The most recent registration is a S-3 filed 2026-05-19. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.